Back to all studiesWithdrawnNCT00766064
Effects of Paliperidone in PTSD (PTSD)
Medication studyAges 18–65United States
The study in practiceUnderstand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Activities
- Medication described in the protocol
- Compensation
- Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarifyThis summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Study clarityThings to check before joining
Study start dateSeptember 2008
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00766064
- Official title
Show the full official title
Effects of Paliperidone in Posttraumatic Stress Disorder (PTSD)
Need help understanding this study?
Leave your email and we’ll get in touch to discuss your questions and possible next steps.
A listed location does not confirm current availability.
FAQQuestions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including Paliperidone.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
Explore other studiesWant to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me